MyFinsight
Home
Blog
About
Contact
Download
Download image
Net product revenue
$868,453K
Interest income
$21,924K
Net income
$158,687K
Other liabilities
$67,994K
Stock-based compensation
$44,895K
Acquired in-process
research & development...
$34,250K
Prepaid expenses and
other assets
-$31,787K
Intangible amortization
$23,845K
Canceled cashflow
$731,690K
Trade payables
$3,949K
Inventory
-$1,841K
Depreciation and impairment
of long-lived...
$1,490K
Other non-cash
expenses
$1,325K
Debt issuance costs
amortization
$647K
Stock appreciation
rights market...
$65K
Net cash provided by
operating activities
$348,199K
Canceled cashflow
$22,576K
Cost of product sold
$198,315K
Research and development
$144,923K
Sales and marketing
$112,136K
General and
administrative
$100,065K
Income tax expense
$56,377K
Stock-based compensation
$44,960K
Other segment items
$34,930K
Depreciation and
amortization
$25,335K
Interest expense
$14,649K
Net increase in
cash, cash...
$299,501K
Canceled cashflow
$48,698K
Trade receivables
$13,754K
Deferred taxes
-$7,301K
Amortization of premiums and
accretion of discounts on...
$1,521K
Proceeds from maturities
and sales of...
$81,062K
Proceeds from exercised
options
$10,205K
Net cash used in
investing activities
-$39,649K
Net cash used in
financing activities
-$9,049K
Canceled cashflow
$81,062K
Canceled cashflow
$10,205K
Purchase of investment
securities
$86,151K
Principal repayment of
long-term debt
$16,250K
Payment of milestones
$19,250K
Payment of upfront fee
related to license...
$15,000K
Purchase of property and
equipment
$310K
Payments of employee
withholding taxes related to...
$3,004K
Back
Back
Cash Flow
source: myfinsight.com
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)